Evaxion biotech to host full-year 2020 corporate update conference call & webcast on april 6

Copenhagen, denmark, march 30, 2021 (globe newswire) -- evaxion biotech a/s (nasdaq: evax), a clinical-stage biotechnology company specializing in the development of ai-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today that it will present its full-year financial results for 2020 on april 6.
EVAX Ratings Summary
EVAX Quant Ranking